PTGX — Protagonist Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Protagonist Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	133	306	327	237	342
Net Total Receivables	7.5	3.82	5.33	0.052	10.3
Prepaid Expenses
Total Other Current Assets
Total Current Assets	145	316	341	243	356
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.72	6.41	6.73	4.63	2.15
Long Term Investments
Other Long Term Assets
Total Assets	155	324	348	248	358
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	35.4	40.2	44	31.2	21.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	75	44.9	47.7	32.3	21.3
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	80	280	300	216	337
Total Liabilities & Shareholders' Equity	155	324	348	248	358
Total Common Shares Outstanding